5
Participants
Start Date
June 30, 2011
Primary Completion Date
February 29, 2012
Study Completion Date
March 31, 2012
Interferon Gamma-1b
Interferon gamma-1b (Actimmune®, InterMune, Inc, Brisbane, CA 94005) was supplied to participants in single-use dropperettes. Each dropperette contained approximately 0.2 mL of interferon gamma-1b (Actimmune®). Participants received 28 dropperettes at the baseline visit and were instructed to place four drops (approximately 7 μg per drop) topically on the cornea of the study eye four times per day for seven days.
National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda
National Eye Institute (NEI)
NIH